Article
An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
The pharmacogenomics journal - 1 Aug 2013
Winder T, Wilson P M, Yang D, Zhang W, Ning Y, Power D G, Bohanes P, Gerger A, Tang L H, Shah M, Lenz H-J
Abstract excerpt
The 5-year survival rate for gastric adenocarcinoma (GA) remains only 40% and biomarkers to identify patients at high risk of tumor recurrence are urgently needed. Secreted protein acidic and rich in cysteine (SPARC) is an extracellular matrix glycoprotein that mediates cell matrix interactions, and upregulation of SPARC can promote tumor progression and metastasis. This study investigated whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
